A controlled trial using intravenous infusion of soya oil emulsion in the treatment of children with cystic fibrosis.

Five children with cystic fibrosis were given repeated intravenous infusions of soya 
oil emulsion (Intralipid) for 12 to 18 months and the effects 
on growth, health, sweat chloride and pancreatic enzyme activity compared with 
a control group. No beneficial effect was demonstrated and it is 
recommended that this form of therapy has no place in the 
routine treatment of children with cystic fibrosis. It is possible that 
treatment may have modified the degree of weight loss noted after 
12 months of age. The lack of other beneficial effects and 
the problems involved in long-term Intralipid infusion should preclude the use 
of this form of therapy in the routine treatment of children 
with cystic fibrosis. 